- Home
- SKYX vs HLVX Comparison
SKYX vs HLVX Comparison
Compare SKYX & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYX
- HLVX
- Stock Information
- Founded
- SKYX 2004
- HLVX 2020
- Country
- SKYX United States
- HLVX United States
- Employees
- SKYX N/A
- HLVX N/A
- Industry
- SKYX Building Products
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- SKYX Consumer Discretionary
- HLVX Health Care
- Exchange
- SKYX Nasdaq
- HLVX Nasdaq
- Market Cap
- SKYX 99.2M
- HLVX 83.7M
- IPO Year
- SKYX 2022
- HLVX 2022
- Fundamental
- Price
- SKYX $1.28
- HLVX $1.96
- Analyst Decision
- SKYX Strong Buy
- HLVX Hold
- Analyst Count
- SKYX 2
- HLVX 5
- Target Price
- SKYX $3.50
- HLVX $2.33
- AVG Volume (30 Days)
- SKYX 481.8K
- HLVX 199.7K
- Earning Date
- SKYX 05-14-2025
- HLVX 05-08-2025
- Dividend Yield
- SKYX N/A
- HLVX N/A
- EPS Growth
- SKYX N/A
- HLVX N/A
- EPS
- SKYX N/A
- HLVX N/A
- Revenue
- SKYX $87,412,993.00
- HLVX N/A
- Revenue This Year
- SKYX $23.10
- HLVX N/A
- Revenue Next Year
- SKYX $27.44
- HLVX N/A
- P/E Ratio
- SKYX N/A
- HLVX N/A
- Revenue Growth
- SKYX 12.42
- HLVX N/A
- 52 Week Low
- SKYX $0.75
- HLVX $1.34
- 52 Week High
- SKYX $2.14
- HLVX $15.60
- Technical
- Relative Strength Index (RSI)
- SKYX 48.47
- HLVX 59.85
- Support Level
- SKYX $1.26
- HLVX $1.82
- Resistance Level
- SKYX $1.40
- HLVX $1.89
- Average True Range (ATR)
- SKYX 0.11
- HLVX 0.07
- MACD
- SKYX -0.02
- HLVX -0.01
- Stochastic Oscillator
- SKYX 6.25
- HLVX 63.64
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.